EAN57 inhibitors are a class of chemical compounds characterized by their specific ability to inhibit the EAN57 protein, a member of a larger protein family involved in cellular signaling pathways. Structurally, these inhibitors share a core molecular scaffold that enables strong binding affinity and specificity to the active site of EAN57. The binding interaction typically occurs through non-covalent forces, such as hydrogen bonding, van der Waals interactions, and hydrophobic contacts. This structural arrangement allows for the modulation of EAN57's enzymatic activity, leading to a decrease in its biological function within cells. Many EAN57 inhibitors contain a variety of aromatic or heterocyclic rings that enhance their stability and improve their binding properties, often with tailored side chains or substituents that confer specificity to the EAN57 protein.
In terms of their chemical properties, EAN57 inhibitors are often designed to have favorable pharmacokinetic characteristics, such as optimal solubility, stability, and bioavailability. This allows them to effectively reach their target protein and maintain inhibitory activity over time. These compounds are synthesized using a variety of organic chemistry techniques, including multi-step synthesis and functional group modifications, which allow for the fine-tuning of their activity and selectivity. Depending on their molecular structure, EAN57 inhibitors can vary widely in their molecular weight, polarity, and overall chemical makeup, offering diverse profiles in terms of stability and interaction with biological membranes. The chemical diversity within this class of inhibitors makes them an intriguing subject of study for understanding protein function regulation and the dynamics of cellular signaling processes.
SEE ALSO...
Items 1 to 10 of 11 total
Display:
| Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
|---|---|---|---|---|---|---|
Taxol | 33069-62-4 | sc-201439D sc-201439 sc-201439A sc-201439E sc-201439B sc-201439C | 1 mg 5 mg 25 mg 100 mg 250 mg 1 g | $41.00 $74.00 $221.00 $247.00 $738.00 $1220.00 | 39 | |
Stabilizes microtubules, potentially disrupting cilia assembly and function. | ||||||
Nocodazole | 31430-18-9 | sc-3518B sc-3518 sc-3518C sc-3518A | 5 mg 10 mg 25 mg 50 mg | $59.00 $85.00 $143.00 $247.00 | 38 | |
Destabilizes microtubules, which could impair cilia formation and function. | ||||||
Colchicine | 64-86-8 | sc-203005 sc-203005A sc-203005B sc-203005C sc-203005D sc-203005E | 1 g 5 g 50 g 100 g 500 g 1 kg | $100.00 $321.00 $2289.00 $4484.00 $18207.00 $34749.00 | 3 | |
Binds to tubulin, affecting microtubule polymerization and cilia formation. | ||||||
Podophyllotoxin | 518-28-5 | sc-204853 | 100 mg | $84.00 | 1 | |
Inhibits microtubule assembly, could disrupt ciliary processes. | ||||||
Vinblastine | 865-21-4 | sc-491749 sc-491749A sc-491749B sc-491749C sc-491749D | 10 mg 50 mg 100 mg 500 mg 1 g | $102.00 $235.00 $459.00 $1749.00 $2958.00 | 4 | |
Disrupts microtubule assembly, potentially impairing ciliary function. | ||||||
Eribulin | 253128-41-5 | sc-507547 | 5 mg | $865.00 | ||
Inhibits microtubule growth, possibly affecting cilia. | ||||||
Griseofulvin | 126-07-8 | sc-202171A sc-202171 sc-202171B | 5 mg 25 mg 100 mg | $85.00 $220.00 $598.00 | 4 | |
Disrupts microtubule function, potentially impacting ciliogenesis. | ||||||
Docetaxel | 114977-28-5 | sc-201436 sc-201436A sc-201436B | 5 mg 25 mg 250 mg | $87.00 $332.00 $1093.00 | 16 | |
Stabilizes microtubules, potentially affecting ciliary dynamics. | ||||||
Mebendazole | 31431-39-7 | sc-204798 sc-204798A | 5 g 25 g | $46.00 $89.00 | 2 | |
Disrupts microtubule synthesis, potentially affecting ciliary structure. | ||||||
Albendazole | 54965-21-8 | sc-210771 | 100 mg | $213.00 | 1 | |
Affects microtubule polymerization, potentially impacting cilia. | ||||||